Healthcare >> CEO Interviews >> October 26, 2004
B. LYNNE PARSHALL is Director, Executive Vice President and Chief
Financial Officer of Isis Pharmaceuticals. She is responsible for
overseeing the operations of development chemistry, manufacturing and
pharmaceutics, finance, legal, patent affairs and is also very involved
in the company's investor relations and business development activities.
Ms. Parshall has been with Isis for 13 years. Previously, Ms. Parshall
was a Partner with the firm of Cooley Godward LLP where she represented
several health care companies in a general practice specializing in
corporate partnering and other technology-based transactions. Ms.
Parshall received her JD at Stanford Law School, Stanford, California,
and her BA from Harvard University, Cambridge, Massachusetts. Ms.
Parshall is currently a member of the Board of Trustees of The Bishop's
School and the Surf Soccer Board of Directors. She is also a member of
the Licensing Executives Society and a member of the American,
Californian, and San Diego bar associations. Profile
Pharmaceuticals and a picture of the things you're doing at the present
time?
Ms. Parshall: ISIS Pharmaceuticals is a biotechnology
